SAB Biotherapeutics Inc (SABS) — Net Asset Quality Index

Latest as of December 2025: 87.7%

SAB Biotherapeutics Inc (SABS) has a Net Asset Quality Index of 87.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $172.81 Million minus total liabilities of $21.32 Million yields net assets of $151.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check SABS asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Quality Index

87.7%
Equity / Total Assets

Net Assets

$151.49 Million
USD

Total Assets

$172.81 Million
USD

Total Liabilities

$21.32 Million
USD

SAB Biotherapeutics Inc Net Asset Quality Index Over Time (2019–2025)

This chart shows how SAB Biotherapeutics Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the index stands at 87.7%, representing net assets of $151.49 Million against total assets of $172.81 Million USD. See SAB Biotherapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for SAB Biotherapeutics Inc (2019–2025)

The table below presents the year-by-year Net Asset Quality Index for SAB Biotherapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see SAB Biotherapeutics Inc market cap and net worth.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 87.7% $151.49 Million $172.81 Million $21.32 Million ▲ +28.9 pp
2024 58.8% $25.97 Million $44.20 Million $18.23 Million ▼ -9.5 pp
2023 68.3% $57.30 Million $83.94 Million $26.64 Million ▲ +7.2 pp
2022 61.0% $31.06 Million $50.90 Million $19.85 Million ▲ +13.5 pp
2021 47.5% $38.55 Million $81.14 Million $42.59 Million ▼ -21.5 pp
2020 69.0% $39.01 Million $56.54 Million $17.53 Million ▲ +81.8 pp
2019 -12.8% $-2.31 Million $18.00 Million $20.31 Million
pp = percentage points